
Rivaroxaban Tablets
Deep Vein Thrombosis, Pulmonary Embolism
10mg
Rivaroxaban 10mg tablets, used in the management of deep vein thrombosis, pulmonary embolism and stroke prevention in atrial fibrillation.
Rivaroxaban is an oral factor Xa inhibitor used to treat or prevent selected blood clots. The treatment plan depends on the indication, kidney function, bleeding risk and other medicines.

Deep Vein Thrombosis, Pulmonary Embolism
10mg
Rivaroxaban 10mg tablets, used in the management of deep vein thrombosis, pulmonary embolism and stroke prevention in atrial fibrillation.
Listings are for comparison only; suitability and supply depend on the diagnosed indication, prescription, kidney and interaction checks, and pharmacy review.
Uses may include stroke prevention in atrial fibrillation, deep vein thrombosis and pulmonary embolism. It is not appropriate for every heart valve or clotting condition.
Rivaroxaban inhibits factor Xa, reducing thrombin generation and clot formation. Routine INR monitoring does not guide its effect, but clinical and laboratory review is still needed.
Review kidney and liver function, previous bleeding, pregnancy, planned surgery or dental work, and all anticoagulants, antiplatelets, NSAIDs and interacting antifungal, antiviral or seizure medicines. Tell clinicians about rivaroxaban before procedures.
Seek urgent help for vomiting or coughing blood, black stools, uncontrolled bleeding, severe headache, head injury, fainting, blood in urine, sudden weakness or speech difficulty, or extensive unexplained bruising.

Understand how antiplatelet and anticoagulant medicines act on different parts of clot formation, and why indication and duration matter.
Read guide
What anticoagulant and antiplatelet users should tell a pharmacist about NSAIDs, aspirin, supplements, traditional medicines and bleeding.
Read guide